| J0897 | Injection, denosumab, 1 mg | 14,940 | $20 | $268.9K |
| J3262 | Injection, tocilizumab, 1 mg | 38,360 | $10 | $191.8K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 5,300 | $30 | $180.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,120 | $90 | $104.1K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 12,390 | $10 | $99.1K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,150 | $30 | $81.9K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 15,000 | $1 | $60K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 4,600 | $10 | $50.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 270 | $100 | $25.9K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 330 | $50 | $18K |